PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50125F61018CLIN 1005 CGMP adjuvant: clinical or — Glaxosmithkline LLC

Glaxosmithkline LLC holds $3.0B across 194 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 5 related awards under parent 75A50122D00002. PoP ended Dec 12, 2025 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Barda - Aspr / Daappo / Barda Dcma

Awarding office

Glaxosmithkline LLC

Recipient

Dec 12, 2025

PoP end

$8.8M

Obligated

$8.8M

Potential

541714

NAICS

6505

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Glaxosmithkline LLC — $90

Contract facts

Federal

Contract number75A50125F61018

Also listed as75A50122D00002-75A50125F61018

AgencyBarda - Aspr / Daappo / Barda Dcma

Awarding officeBarda - Aspr / Daappo / Barda Dcma

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentGlaxosmithkline LLC

CAGE667E9

UEIFRHTPHMZMX47

NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSC6505

Parent IDIQ / IDV75A50122D00002

Place of performanceDURHAM NC

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startJun 13, 2025

PoP end (current)Dec 12, 2025

Obligated$8.8M

Current value$8.8M

Potential value$8.8M

CLIN 1005, CGMP ADJUVANT: CLINICAL OR COMMERCIAL SCALE BULK LOT(S) is a federal award for Barda - Aspr / Daappo / Barda Dcma held by Glaxosmithkline LLC. Estimated value $8.8M ($8.8M obligated). Current period of performance ends Dec 12, 2025. Place of performance: DURHAM NC.

CLIN 1005, CGMP ADJUVANT: CLINICAL OR COMMERCIAL SCALE BULK LOT(S)

Recompete timing

Public

● Past PoP end (269 days ago)

Current PoP ended Dec 12, 2025 (269 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Glaxosmithkline LLC — $3.0B obligated across 194 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($3.0B) · all agencies

Department of Health and Human Services (HHS)$3.0B · 100%Department of Defense (DOD)$1.7M · 0%Department of Veterans Affairs (VA)$1.5M · 0%Department of State (DOS)$1.2M · 0%

Open full company profile →

Related awards

Same parent · incumbent

75A50126F61020

TWO-WAY IMMUNOGENICITY TESTING ON EXISTING CLINICAL TRIAL SERA TO IMMUNOGENICITY SUPERIOR…

$493K

Oct 29, 2026

15F06724F0001366

GSK TRAVEL VACCINES

$115K

Dec 31, 2026

15F06726F0000234

GSK VACCINES TERMS AND CONDITIONS REMAIN THE SAME - BPA 15F06722A0000187

$105K

Dec 31, 2026

75A50124F61014

THIS TASK ORDER ESTABLISHES SERVICES FOR H5 PANDEMIC READINESS FOR ACQUISITION OF MEDICAL …

$18.4M

Feb 21, 2027

75A50124F61013

THE PURPOSE OF THIS TASK ORDER IS TO ESTABLISH FILL/FINISH ACTIVITIES FOR ADJUVANT (AS03) …

$15.4M

Feb 21, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75A50125F61018?

75A50125F61018 (CLIN 1005 CGMP adjuvant: clinical or) is a Barda - Aspr / Daappo / Barda Dcma award with a potential value of $8.8M, currently held by Glaxosmithkline LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75A50125F61018?

Barda - Aspr / Daappo / Barda Dcma awarded 75A50125F61018 to Glaxosmithkline LLC (potential $8.8M).

Who is the incumbent on 75A50125F61018?

Glaxosmithkline LLC is the incumbent with $3.0B across 194 related awards in SCOUT’s public footprint. The current period of performance ends Dec 12, 2025.

When does Glaxosmithkline LLC’s 75A50125F61018 come up for recompete?

SCOUT tracks a period-of-performance end of Dec 12, 2025. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 75A50125F61018 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action May 28, 2026